Horizon Investments’s Repligen RGEN Stock Holding History

Horizon Investments’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-515	Closed	-$84.4K	–	1493
2025 Q4	$84.4K	Buy	+515	New	+$80.7K	﹤0.01%	1082

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Horizon Investments's RGEN Position: Q1 2026 in Review

Horizon Investments sold out of Repligen (RGEN) in Q1 2026, closing a stake of 515 shares — an estimated $84.4K sold.

Horizon Investments first reported a position in RGEN in Q4 2025 and held it in 1 quarter. The position peaked at $84.4K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

Horizon Investments reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
Horizon Investments sold 515 Repligen shares in Q1 2026, an estimated $84.4K.
Horizon Investments first reported a position in Repligen in Q4 2025 and held it in 1 quarter.
Horizon Investments's Repligen position peaked at $84.4K in Q4 2025.
441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.